{"id":565257,"date":"2025-02-05T18:32:25","date_gmt":"2025-02-06T02:32:25","guid":{"rendered":"https:\/\/nai500.com\/blog\/2025\/02\/%e7%be%8e%e8%82%a1%e5%9f%ba%e5%9b%a0%e7%bb%84%e8%82%a1%e7%a5%a8%e6%8a%95%e8%b5%84%e6%8c%87%e5%8d%97-%e6%9c%a8%e5%a4%b4%e5%a7%90-%e5%9f%ba%e5%9b%a0%e7%bb%84%e9%9d%a9%e5%91%bd\/"},"modified":"2025-02-05T18:33:03","modified_gmt":"2025-02-06T02:33:03","slug":"%e7%be%8e%e8%82%a1%e5%9f%ba%e5%9b%a0%e7%b5%84%e8%82%a1%e7%a5%a8%e6%8a%95%e8%b3%87%e6%8c%87%e5%8d%97%ef%bc%9a%e6%8a%bc%e6%b3%a8%e6%9c%a8%e9%a0%ad%e5%a7%90%e7%9a%84%e5%9f%ba%e5%9b%a0%e7%b5%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2025\/02\/%e7%be%8e%e8%82%a1%e5%9f%ba%e5%9b%a0%e7%b5%84%e8%82%a1%e7%a5%a8%e6%8a%95%e8%b3%87%e6%8c%87%e5%8d%97%ef%bc%9a%e6%8a%bc%e6%b3%a8%e6%9c%a8%e9%a0%ad%e5%a7%90%e7%9a%84%e5%9f%ba%e5%9b%a0%e7%b5%84\/","title":{"rendered":"\u7f8e\u80a1\u57fa\u56e0\u7d44\u80a1\u7968\u6295\u8cc7\u6307\u5357\uff1a\u62bc\u6ce8\u6728\u982d\u59d0\u7684\u201c\u57fa\u56e0\u7d44\u9769\u547d\u201d"},"content":{"rendered":"<p>\u904e\u53bb\u5e7e\u5e74\uff0c\u57fa\u56e0\u7d44\u9818\u57df\u7684\u767c\u5c55\u8b93\u6295\u8cc7\u8005\u770b\u5230\u4e86\u771f\u6b63\u7684\u672a\u4f86\u6f5b\u529b\u3002\u57fa\u56e0\u7d44\u5b78\u6240\u7814\u7a76\u7684\u662f\u57fa\u56e0\u5982\u4f55\u5f71\u97ff\u4eba\u985e\u5065\u5eb7\u53ca\u75be\u75c5\uff0c\u96a8\u8457\u6e2c\u5e8f\u6280\u8853\u6210\u672c\u7684\u964d\u4f4e\u8207\u7cbe\u5ea6\u7684\u63d0\u5347\uff0c\u4e00\u5927\u6279\u5c08\u6ce8\u4e8e\u57fa\u56e0\u7d44\u7814\u7a76\u7684\u4f01\u696d\u76f8\u7e7c\u6e67\u73fe\uff0c\u9019\u4e5f\u70ba\u6295\u8cc7\u8005\u62bc\u6ce8\u7f8e\u80a1\u57fa\u56e0\u7d44\u80a1\u7968\u63d0\u4f9b\u4e86\u591a\u6a23\u5316\u7684\u9078\u64c7\u3002<\/p>\n<p>\u65b9\u821f\u6295\u8cc7\uff08Ark Investment Management\uff09\u7684\u201c\u6728\u982d\u59d0\u201d\u5c31\u66fe\u63d0\u51fa\u201c\u57fa\u56e0\u7d44\u9769\u547d\u201d\u9019\u4e00\u5b8f\u5927\u7406\u5ff5\uff0c\u8a8d\u70ba\u8a72\u9818\u57df\u7684\u7a81\u7834\u5c07\u5f15\u9818\u65b0\u4e00\u4ee3\u7684\u91ab\u7642\u9769\u547d\u3002\u7136\u800c\uff0c\u5118\u7ba1\u6280\u8853\u9032\u6b65\u986f\u8457\uff0c\u9019\u4e9b\u516c\u53f8\u80a1\u50f9\u8868\u73fe\u4e26\u4e0d\u7e3d\u662f\u5f88\u7406\u60f3\uff0c2020\u5e74\u81f32024\u5e74\u9593\uff0c\u6a19\u666e\u751f\u7269\u79d1\u6280\u7cbe\u9078\u884c\u696d\u6307\u6578S&amp;P Biotechnology Select Industry Index\u4e0d\u6f32\u53cd\u8dcc\u3002<\/p>\n<p>\u5c55\u671b\u672a\u4f86\uff0c\u6295\u8cc7\u8005\u53ef\u4ee5\u95dc\u6ce8\u4ee5\u4e0b\u57fa\u56e0\u7d44\u884c\u696d\u7684\u4e09\u500b\u5927\u985e\uff1a<\/p>\n<ul>\n<li>\u7b2c\u4e00\u662f\u57fa\u56e0\u6e2c\u5e8f\u8207\u5206\u6790\uff1b<\/li>\n<li>\u7b2c\u4e8c\u662f\u57fa\u56e0\u6aa2\u6e2c\u8207\u8a3a\u65b7\uff1b<\/li>\n<li>\u7b2c\u4e09\u662f\u57fa\u56e0\u7de8\u8f2f<\/li>\n<\/ul>\n<h2>2025\u5e74\u7cbe\u9078\u7f8e\u80a1\u57fa\u56e0\u7d44\u80a1\u7968<\/h2>\n<p>\u5728\u6e2c\u5e8f\u9818\u57df\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ILMN\">Illumina\uff08\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aILMN\uff09<\/a>\u64c1\u6709\u7d55\u5c0d\u5e02\u5834\u4e3b\u5c0e\u5730\u4f4d\uff0c\u6e2c\u5e8f\u5100\u5168\u7403\u88dd\u6a5f\u91cf\u8d852.5\u842c\u53f0\uff0c\u5168\u7403\u5e02\u5834\u4efd\u984d\u572880%\u5de6\u53f3\u3002\u8a72\u516c\u53f8\u7684\u77ed\u8b80\u9577\u6e2c\u5e8f\u6280\u8853\u70ba\u8a31\u591a\u7814\u7a76\u8207\u81e8\u5e8a\u61c9\u7528\u63d0\u4f9b\u4e86\u57fa\u790e\u3002\u96a8\u8457\u764c\u75c7\u6aa2\u6e2c\u8207\u5168\u57fa\u56e0\u7d44\u5206\u6790\u7684\u6301\u7e8c\u589e\u9577\uff0c\u8a72\u516c\u53f8\u7684NovaSeq X\u6e2c\u5e8f\u5e73\u81fa\u9010\u6f38\u6210\u70ba\u516c\u53f8\u696d\u7e3e\u7684\u91cd\u8981\u63a8\u52d5\u529b\u3002\u5118\u7ba1Illumina\u57282024\u5e74\u524d\u4e09\u5b63\u5ea6\u7684\u71df\u6536\u540c\u6bd4\u4e0b\u964d5.1%\uff0c\u4f46\u5b83\u5728\u6e2c\u5e8f\u5e02\u5834\u7684\u9f8d\u982d\u5730\u4f4d\u4ecd\u7136\u7a69\u56fa\u3002<\/p>\n<p>\u5c08\u6ce8\u65bcRNA\u7642\u6cd5\u7684Avidity Biosciences\uff08RNA\uff09\u81f4\u529b\u65bc\u6297\u9ad4\u5be1\u6838\u82f7\u9178\u5076\u806f\u7269\uff08AOCs\uff09\u3002AOC\u878d\u5408\u4e86\u5be1\u6838\u82f7\u9178\u6280\u8853\u548c\u6297\u9ad4\u7684\u512a\u52e2\uff0c\u88ab\u8a8d\u70ba\u5177\u6709\u63d0\u4f9b\u7cbe\u78ba\u9776\u5411\u6cbb\u7642\u7684\u6f5b\u529b\u3002\u516c\u53f8\u81e8\u5e8a\u7814\u767c\u7ba1\u7dda\u805a\u7126\u5305\u62ec\u808c\u71df\u990a\u4e0d\u826f\u5728\u5167\u7684\u4e09\u7a2e\u7f55\u898b\u808c\u8089\u75be\u75c5\uff0c\u5019\u9078\u85e5\u7269\u5206\u5225\u70baDel-desiran (AOC 1001)\u3001del-brax (AOC 1020)\uff0c\u4ee5\u53cadel-zota (AOC 1044)\u3002\u76ee\u524d\u516c\u53f8\u96d6\u672a\u76c8\u5229\uff0c\u4f46\u57282024\u5e74\u516c\u4f48\u4e86\u7a4d\u6975\u7684\u81e8\u5e8a\u8a66\u9a57\u6578\u64da\uff0c\u4e5f\u56e0\u6b64\u5438\u5f15\u4e86\u76f8\u7576\u591a\u7684\u5e02\u5834\u95dc\u6ce8\u3002<\/p>\n<p>Exact Sciences\uff08EXAS\uff09\u6191\u85c9\u5bb6\u7528\u7d50\u8178\u764c\u7be9\u67e5\u7522\u54c1\u201cCologuard\u201d\u5d84\u9732\u982d\u89d2\uff0c\u540c\u6642\u901a\u904e\u6536\u8cfcGenomic Health\u5c07\u764c\u75c7\u8a3a\u65b7\u5e73\u81faOncotype DX\u7d0d\u5165\u81ea\u5df1\u7684\u7522\u54c1\u7dda\u3002\u672a\u4f86\uff0c\u8a72\u516c\u53f8\u9084\u5c07\u4e0a\u5e02\u5206\u5b50\u6b98\u7559\u75c5\u6aa2\u6e2c\u7522\u54c1Oncodetect\u548c\u6cdb\u764c\u65e9\u7be9\u7522\u54c1Cancerguard\u3002Exact Sciences\u9810\u8a08\u5168\u5e74\u6536\u5165\u5c07\u540c\u6bd4\u589e\u957710%\u81f328\u5104\u7f8e\u5143\uff0c\u540c\u6642\u9810\u8a082026\u5e74\u5be6\u73fe\u6de8\u5229\u6f64\u8f49\u6b63\u3002<\/p>\n<p>\u57fa\u56e0\u6aa2\u6e2c\u516c\u53f8Fulgent Testing\uff08FLGT\uff09\u56e0\u63d0\u4f9b\u8d85\u904e18,000\u7a2e\u6aa2\u6e2c\u9805\u76ee\u800c\u53d7\u5230\u91ab\u751f\u8207\u60a3\u8005\u7684\u5ee3\u6cdb\u9752\u775e\u3002\u9019\u4e9b\u9805\u76ee\u4e0d\u50c5\u6db5\u84cb\u764c\u75c7\u7be9\u67e5\uff0c\u4e5f\u6d89\u53ca\u7f55\u898b\u75be\u75c5\u53ca\u65b0\u751f\u5152\u57fa\u56e0\u6aa2\u6e2c\u30022024\u5e74\u7b2c\u4e09\u5b63\u5ea6\uff0c\u516c\u53f8\u6838\u5fc3\u6536\u5165\uff08\u4e0d\u542b\u65b0\u51a0\u6aa2\u6e2c\uff09\u540c\u6bd4\u589e\u95779%\uff0c\u986f\u793a\u51fa\u591a\u5143\u5316\u7522\u54c1\u7dda\u7684\u97cc\u6027\u3002<\/p>\n<p>Ionis Pharmaceuticals\uff08IONS\uff09\u5247\u5728RNA\u9776\u5411\u85e5\u7269\u7814\u767c\u4e2d\u7a4d\u7d2f\u4e86\u6df1\u539a\u7684\u5be6\u529b\uff0c\u806f\u624bBiogen\u63a8\u51fa\u4e86\u9996\u6b3e\u91dd\u5c0dALS\uff08\u808c\u840e\u7e2e\u6027\u810a\u9ad3\u5074\u7d22\u786c\u5316\u75c7\uff09\u57fa\u56e0\u81f4\u75c5\u539f\u56e0\u7684\u85e5\u7269Qalsody\u3002\u516c\u53f8\u660e\u661f\u7522\u54c1Spinraza\u662f\u6700\u5927\u7684\u6536\u5165\u4f86\u6e90\uff0c\u70ba\u516c\u53f8\u5b75\u5316\u66f4\u591a\u5275\u65b0\u85e5\u7269\u63d0\u4f9b\u8cc7\u91d1\u652f\u6301\u3002\u96d6\u7136Ionis\u5c1a\u672a\u76c8\u5229\uff0c\u4f46\u5145\u8db3\u7684\u73fe\u91d1\u5132\u5099\uff0825\u5104\u7f8e\u5143\uff09\u4ee5\u53ca\u591a\u9805\u6b63\u5728\u63a8\u9032\u4e2d\u7684\u7814\u767c\u9805\u76ee\u70ba\u516c\u53f8\u7684\u9577\u671f\u50f9\u503c\u63d0\u4f9b\u4e86\u80cc\u66f8\u3002<\/p>\n<p>\u5728\u57fa\u56e0\u7de8\u8f2f\u9818\u57df\uff0cCRISPR Therapeutics\uff08CRSP\uff09\u8207Vertex Pharmaceuticals\u5408\u4f5c\u7814\u767c\u7684\u57fa\u56e0\u7642\u6cd5Casgevy\u7372\u5f97FDA\u6279\u51c6\uff0c\u7528\u65bc\u6cbb\u7642\u942e\u72c0\u7d30\u80de\u75c5\u8207\u03b2\u5730\u4e2d\u6d77\u8ca7\u8840\u3002\u9019\u662f\u9996\u500b\u5229\u7528CRISPR\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u7372\u6279\u4e0a\u5e02\u7684\u7642\u6cd5\uff0c\u5f15\u767c\u4e86\u884c\u696d\u8f5f\u52d5\u3002\u5118\u7ba1CRISPR\u7576\u524d\u5c1a\u672a\u76c8\u5229\uff0c\u4f46\u5728\u5ee3\u95ca\u7684\u764c\u75c7\u3001\u514d\u75ab\u548c\u5fc3\u8840\u7ba1\u6cbb\u7642\u8cfd\u9053\u4e0a\u5df2\u5177\u5099\u5148\u767c\u512a\u52e2\u3002<\/p>\n<p>\u57fa\u56e0\u7d44\u6295\u8cc7\u5c0d\u65bc\u8a31\u591a\u6295\u8cc7\u4eba\u4f86\u8aaa\u4e26\u4e0d\u7c21\u55ae\u3002\u8a31\u591a\u516c\u53f8\u7531\u9802\u5c16\u79d1\u5b78\u5bb6\u6216\u8afe\u734e\u5f97\u4e3b\u5275\u8fa6\uff0c\u4f46\u5e38\u5e38\u56e0\u70ba\u7814\u767c\u9032\u5c55\u7684\u4e0d\u78ba\u5b9a\u6027\uff0c\u80a1\u50f9\u6ce2\u52d5\u5287\u70c8\u3002\u7136\u800c\uff0c\u5982\u679c\u5c07\u57fa\u56e0\u7d44\u4f01\u696d\u7684\u5546\u696d\u6a21\u5f0f\u6bd4\u4f5c\u79d1\u6280\u516c\u53f8\uff0c\u6216\u8a31\u5c31\u80fd\u66f4\u597d\u5730\u7406\u89e3\uff1a\u6e2c\u5e8f\u516c\u53f8\u7336\u5982\u6578\u64da\u8655\u7406\u5de8\u982d\uff0c\u6aa2\u6e2c\u516c\u53f8\u985e\u4f3c\u65bc\u63d0\u4f9b\u95dc\u9375\u4fe1\u606f\u7684\u96fb\u5546\u5e73\u81fa\uff0c\u800c\u5c1a\u5728\u9a57\u8b49\u968e\u6bb5\u7684\u57fa\u56e0\u7de8\u8f2f\u4f01\u696d\u5247\u66f4\u50cf\u5c1a\u7121\u6536\u5165\u3001\u537b\u6709\u6a5f\u6703\u6191\u85c9\u6280\u8853\u8b8a\u9769\u5728\u672a\u4f86\u5927\u653e\u7570\u5f69\u7684\u521d\u5275\u516c\u53f8\u3002<\/p>\n<p>\u5982\u4eca\uff0c\u96a8\u8457\u57fa\u56e0\u7d44\u5b78\u5728\u91ab\u7642\u53ca\u79d1\u7814\u9818\u57df\u7684\u6ef2\u900f\u4e0d\u65b7\u52a0\u6df1\uff0c\u5e02\u5834\u5c0d\u57fa\u56e0\u7d44\u516c\u53f8\u7684\u9700\u6c42\u52e2\u5fc5\u6301\u7e8c\u6500\u5347\u3002\u7121\u8ad6\u662f\u9078\u64c7\u5c08\u6ce8\u67d0\u4e00\u500b\u7d30\u5206\u9580\u985e\uff0c\u9084\u662f\u63a1\u7528\u591a\u5143\u5316\u5efa\u5009\u7684\u201c\u7d44\u5408\u7b56\u7565\u201d\uff0c\u5c0d\u65bc\u6709\u8010\u5fc3\u4e14\u6ce8\u91cd\u9577\u671f\u50f9\u503c\u7684\u6295\u8cc7\u8005\u800c\u8a00\uff0c\u57fa\u56e0\u7d44\u80a1\u7968\u6216\u8a31\u6b63\u662f\u503c\u5f97\u62bc\u6ce8\u7684\u4e0b\u4e00\u7247\u85cd\u6d77\u3002\u5982\u679c\u80fd\u5920\u7a7f\u8d8a\u77ed\u671f\u6ce2\u52d5\uff0c\u642d\u4e0a\u91ab\u7642\u8207\u79d1\u6280\u878d\u5408\u7684\u6771\u98a8\uff0c\u201c\u57fa\u56e0\u7d44\u9769\u547d\u201d\u6216\u5c07\u70ba\u6295\u8cc7\u7d44\u5408\u5e36\u4f86\u5168\u65b0\u7684\u589e\u9577\u6a5f\u9047\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u904e\u53bb\u5e7e\u5e74\uff0c\u57fa\u56e0\u7d44\u9818\u57df\u7684\u767c\u5c55\u8b93\u6295\u8cc7\u8005\u770b\u5230\u4e86\u771f\u6b63\u7684\u672a\u4f86\u6f5b\u529b\u3002\u57fa\u56e0\u7d44\u5b78\u6240\u7814\u7a76\u7684\u662f\u57fa\u56e0\u5982\u4f55\u5f71\u97ff\u4eba\u985e\u5065\u5eb7\u53ca\u75be\u75c5\uff0c\u96a8\u8457\u6e2c\u5e8f [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":565255,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,570,564],"class_list":["post-565257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag-570","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/565257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=565257"}],"version-history":[{"count":3,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/565257\/revisions"}],"predecessor-version":[{"id":565260,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/565257\/revisions\/565260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/565255"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=565257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=565257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=565257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}